Korean Idiopathic Pulmonary Fibrosis Registry

Recruiting

• Conditions: Idiopathic Pulmonary Fibrosis

• Registration Number: NCT04160715
• Lead Sponsor: Seoul National University Hospital

Brief Summary

This is a multicenter prospective registry of IPF patients in South Korea. The Seoul National University Bundang Hospital is the coordination center for the Korean IPF Registry built by a collaboration of the Korean Interstitial Lung Diseases (ILD) Study Group.

Detailed Description

Korean ILD Study Group includes investigators of 30 hospitals. Demographic, pulmonary function, laboratory data, chest CT findings and hospital course of IPF patients are collected.

Study Timeline

• Study Start: 2016-01
• Study First Submitted: 2019-10-30
• Status Verified: 2019-11
• Study First Submitted QC: 2019-11-08
• Last Update Submitted: 2019-11-08
• Study First Posted: 2019-11-13
• Last Update Posted: 2019-11-13
• Primary Completion: 2025-01
• Study Completion: 2026-12

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 3000

Inclusion Criteria

• IPF patients diagnosed by multidisciplinary discussion

Exclusion Criteria

• Other interstitial lung diseases except for IPF
• connective tissue disease-related ILD
• exposure-related ILD

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
survival of IPF	through study completion, an average of 1 year	lung function change (FVC, DLCO)

Secondary Outcome Measures

Name	Time	Method
incidence of comorbidity	through study completion, an average of 1 year	incidence of lung cancer
survival	through study completion, an average of 1 year	death rate
acute exacerbation	through study completion, an average of 1 year	rate of acute exacerbation

Trial Locations

Locations (1)

Seoul National University Bundang Hospital; 🇰🇷 Seongnam-si, Korea, Republic of